Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.1 SEK | -2.90% | -2.59% | +30.30% |
May. 16 | Stefan Berg Leaves the Careium Board Due to New Role | CI |
Apr. 25 | Transcript : Careium AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 733.4 | 218.8 | 561.9 | 732.2 | - | - |
Enterprise Value (EV) 1 | 883.1 | 472.4 | 756.2 | 897.2 | 861.2 | 819.2 |
P/E ratio | 159 x | -19.1 x | 14.8 x | 12.6 x | 10.9 x | 9.84 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.25 x | 0.3 x | 0.68 x | 0.79 x | 0.72 x | 0.66 x |
EV / Revenue | 1.5 x | 0.65 x | 0.92 x | 0.96 x | 0.85 x | 0.74 x |
EV / EBITDA | 13 x | 5.66 x | 5.48 x | 5.98 x | 5.1 x | 4.55 x |
EV / FCF | -4.81 x | -5.26 x | 12.2 x | 20.9 x | 16.6 x | 14.1 x |
FCF Yield | -20.8% | -19% | 8.19% | 4.79% | 6.04% | 7.08% |
Price to Book | 1.33 x | 0.39 x | 0.94 x | 1.09 x | 0.99 x | 0.9 x |
Nbr of stocks (in thousands) | 24,326 | 24,326 | 24,326 | 24,326 | - | - |
Reference price 2 | 30.15 | 8.996 | 23.10 | 30.10 | 30.10 | 30.10 |
Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 587.5 | 725.1 | 824.6 | 931 | 1,017 | 1,109 |
EBITDA 1 | - | 68.1 | 83.5 | 138 | 150 | 169 | 180 |
EBIT 1 | - | 11.5 | 9 | 59.4 | 85 | 99 | 108 |
Operating Margin | - | 1.96% | 1.24% | 7.2% | 9.13% | 9.73% | 9.74% |
Earnings before Tax (EBT) 1 | - | 9.2 | -15.4 | 52.9 | 74 | 85 | 94 |
Net income 1 | 18.8 | 4.5 | -11.4 | 40.8 | 58 | 67 | 75 |
Net margin | - | 0.77% | -1.57% | 4.95% | 6.23% | 6.59% | 6.76% |
EPS 2 | 0.7900 | 0.1900 | -0.4700 | 1.560 | 2.390 | 2.760 | 3.060 |
Free Cash Flow 1 | - | -183.5 | -89.8 | 61.9 | 43 | 52 | 58 |
FCF margin | - | -31.23% | -12.38% | 7.51% | 4.62% | 5.11% | 5.23% |
FCF Conversion (EBITDA) | - | - | - | 44.86% | 28.67% | 30.77% | 32.22% |
FCF Conversion (Net income) | - | - | - | 151.72% | 74.14% | 77.61% | 77.33% |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 9/30/21 | 2/17/22 | 2/16/23 | 2/15/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 162.3 | 178.5 | 174.4 | 175.9 | 196.2 | 194 | 213.8 | 217.3 | 199.4 | 210.7 | 236 | 242 | 242 |
EBITDA 1 | 18.3 | 15.4 | 32.2 | 0.8 | 35.1 | 25.4 | 33 | 44.1 | 35.5 | 34.9 | 38 | 39 | 38 |
EBIT 1 | 0.9 | -3.4 | 14.1 | -18.2 | 16.5 | 7.3 | 14.6 | 20.7 | 16.7 | 19.1 | 22 | 23 | 22 |
Operating Margin | 0.55% | -1.9% | 8.08% | -10.35% | 8.41% | 3.76% | 6.83% | 9.53% | 8.38% | 9.07% | 9.32% | 9.5% | 9.09% |
Earnings before Tax (EBT) 1 | 1.8 | -24.5 | 14.3 | -19.7 | 14.5 | 8 | 19.5 | 15.6 | 9.7 | 18.6 | 18 | 19 | 18 |
Net income 1 | -1.1 | -20.1 | 16.5 | -16.3 | 8.5 | 5.5 | 14.3 | 11.4 | 7.4 | 13.5 | 14 | 15 | 16 |
Net margin | -0.68% | -11.26% | 9.46% | -9.27% | 4.33% | 2.84% | 6.69% | 5.25% | 3.71% | 6.41% | 5.93% | 6.2% | 6.61% |
EPS 2 | -0.0400 | -0.8300 | 0.6800 | -0.6700 | 0.3500 | 0.2300 | 0.5900 | 0.4700 | 0.2700 | 0.5600 | 0.5900 | 0.6300 | 0.5900 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/17/22 | 4/29/22 | 7/15/22 | 10/21/22 | 2/16/23 | 4/27/23 | 7/14/23 | 10/26/23 | 2/15/24 | 4/25/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | 150 | 254 | 194 | 165 | 129 | 87 |
Net Cash position 1 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 2.198 x | 3.037 x | 1.408 x | 1.1 x | 0.7633 x | 0.4833 x |
Free Cash Flow 1 | - | -184 | -89.8 | 61.9 | 43 | 52 | 58 |
ROE (net income / shareholders' equity) | - | 1% | -1.5% | 7% | 9.1% | 9.5% | 9.6% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | 22.70 | 23.30 | 24.60 | 27.70 | 30.50 | 33.50 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 51.1 | 65.9 | 50 | 27 | 44 | 44 |
Capex / Sales | - | 8.7% | 9.09% | 6.06% | 2.9% | 4.33% | 3.97% |
Announcement Date | 9/30/21 | 2/17/22 | 2/16/23 | 2/15/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.30% | 69.47M | |
-5.02% | 12.9B | |
+10.22% | 5.91B | |
-34.37% | 1.72B | |
+3.18% | 1.04B | |
+0.93% | 862M | |
-5.43% | 742M | |
+56.60% | 531M | |
+4.34% | 499M | |
-31.36% | 438M |
- Stock Market
- Equities
- CARE Stock
- Financials Careium AB